Excellent 4.6 out of 5
Plasticizers & Consumer Chemicals

Mono-(2-ethyl-5-oxohexyl) Phthalate (MEOHP) Environmental Toxin Test

This test measures MEOHP, a key marker of exposure to the plasticizer DEHP, so you can identify and reduce your burden of hormone-disrupting phthalates. Lowering exposure may help reduce risks associated with DEHP, including hormonal imbalance, reduced fertility, pregnancy/developmental effects, and metabolic or cardiovascular issues.

With Superpower, you have access to a comprehensive range of biomarker tests.

Test for Mono-(2-ethyl-5-oxohexyl) Phthalate (MEOHP)
Cancel anytime
HSA/FSA eligible
Results in a week
Physician reviewed

Every result is checked

·
CLIA-certified labs

Federal standard for testing

·
HIPAA compliant

Your data is 100% secure

Key Insights

  • See your current exposure to this environmental toxin and how it compares with typical levels.
  • Spot exposure patterns and likely sources you can recognize in daily life, like certain plastics, food packaging, indoor dust, or workplace materials.
  • Understand whether this compound could be nudging hormone balance or adding stress to systems like the liver, kidneys, or endocrine signaling.
  • Support reproductive planning or pregnancy safety by checking for elevations during sensitive life stages.
  • Track trends over time after switching products, adjusting food-storage habits, or changing environments or job tasks.
  • Use results to inform conversations with your clinician about any additional evaluations or targeted reduction strategies.

What is Mono-(2-ethyl-5-oxohexyl) Phthalate (MEOHP)?

MEOHP is a urinary metabolite of DEHP, a high-volume plasticizer used to make polyvinyl chloride (PVC) flexible. Think vinyl flooring, wire insulation, certain food-contact materials, and some medical tubing. DEHP isn’t chemically bound to plastic, so small amounts can migrate into air, dust, and food. People typically encounter it by ingesting food that contacted DEHP-containing materials, breathing indoor air or dust, or through medical devices during procedures. Labs measure MEOHP in urine using mass spectrometry; because DEHP clears relatively quickly, a single urine measurement reflects recent exposure over the past day or two rather than a long-term body burden.

Why it matters: DEHP and its metabolites interact with hormonal pathways (notably anti-androgenic effects), activate receptors that regulate metabolism (like PPARs), and can increase oxidative stress. After exposure, DEHP is absorbed, rapidly transformed in the liver into metabolites such as MEOHP, and excreted by the kidneys. DEHP does not persist for years the way PFAS do, but repeated low-level contact can keep levels detectable. Large biomonitoring studies consistently find phthalate metabolites like MEOHP in a majority of people, a signal that everyday environments can contribute to ongoing exposure, though individual health risk depends on dose, timing, and personal susceptibility.

Why Is It Important to Test For Mono-(2-ethyl-5-oxohexyl) Phthalate (MEOHP)?

MEOHP testing connects a real-world question—did something in my routine recently raise my exposure?—to how DEHP-related metabolites behave in the body. Because this metabolite reflects short-term exposure, a result can help differentiate incidental contact (for example, a takeout meal packaged in soft plastic) from a pattern that suggests repeated sources, like particular workplace materials or frequent use of DEHP-containing products. That distinction matters for understanding symptom clusters that sometimes correlate with phthalate exposure, such as shifts in reproductive hormones, subtle thyroid effects, or signs of oxidative stress. It is also relevant for people with intensive medical device contact, including dialysis or certain infusion therapies. Pregnancy and early childhood are periods of special interest, given evidence that anti-androgenic phthalates may influence fetal and child development, though human studies are largely observational and dose dependent.

At the big-picture level, an MEOHP result is most useful alongside other environmental biomarkers, general health labs, and your lived context. A single value offers a snapshot; repeated measurements, paired with notes about food packaging, home renovations, or occupational tasks, reveal whether you are seeing transient spikes or a steady signal. Over time, that pattern helps you and your clinician judge relevance, weigh trade-offs, and prioritize realistic, evidence-aligned changes. This is the same logic many people use with wearable recovery data: one off-night doesn’t define fitness, but consistent trends do. For environmental exposures, trends and context—not isolated numbers—are what ultimately guide safer choices.

What Insights Will I Get From an MEOHP Test?

Most labs report MEOHP against population-based reference ranges, sometimes including percentiles from national surveys. With environmental toxins, lower values are generally preferable when achievable, and because hydration can dilute or concentrate urine, results may be “creatinine-corrected” to standardize interpretation. Since MEOHP reflects the prior 24–48 hours, repeat testing and notes on recent exposures improve clarity.

Relatively lower values usually signal limited recent contact with DEHP-containing materials and a lower likelihood of short-term stress on hormone signaling or detox pathways. In pregnancy planning or early childhood contexts, lower results are reassuring in that moment in time, while still benefiting from periodic rechecks if circumstances change.

Relatively higher values can indicate recent or ongoing sources—for example, certain flexible PVC materials in the home, workplace, or medical settings—and may correspond with added workload for the liver and kidneys as they process and excrete metabolites. Depending on susceptibility and timing, endocrine-related effects are the most discussed with DEHP-class phthalates; some studies also link higher metabolite levels with markers of oxidative stress. Because spot urine can vary with hydration and daily routines, it is wise to confirm elevations with trends and context, rather than drawing conclusions from a single result.

Bottom line: MEOHP is most meaningful when viewed next to other phthalate metabolites, related health markers, and your day-to-day reality. That integrated view helps distinguish a one-time spike from a persistent exposure pattern and supports informed, practical decisions with your clinician’s guidance.

How This Test Fits Into Real Life

Think of MEOHP as a quick status check after a normal week. If you just renovated a room with new vinyl flooring, ate several meals packaged in soft plastic, or spent long hours in a workshop with flexible PVC, a test can capture the short-term impact. If nothing stands out but results are persistently higher on repeat testing, that’s a clue to look for subtle contributors like specific food-contact items, indoor dust reservoirs, or recurring medical device contact. For many, simple pattern recognition—what happened in the 48 hours before each test—reveals the “aha” moments.

Method and Interpretation Notes

This is a urine test performed by advanced mass spectrometry. Results may be reported as a raw concentration and/or creatinine-normalized value to account for hydration. Because half-life is short, timing matters: results reflect recent exposure and can vary day to day. Inter-lab methods and reference ranges differ, so comparing results to the same lab over time is best. MEOHP is one of several DEHP metabolites; clinicians often consider it alongside related markers to strengthen interpretation. Associations between higher phthalate metabolites and health outcomes come from a mix of animal experiments and human observational studies; they point to plausible risks, but individual results require context and clinical judgment.

Who Might Consider MEOHP Testing?

People curious about everyday exposure who want a concrete, lab-based readout often find it useful. It can be especially informative for those in high-contact settings (e.g., PVC manufacturing, recycling, healthcare with frequent device exposure), for families planning pregnancy, or for individuals experiencing hormone-related concerns where environmental contributors are being considered. Children and pregnant individuals are life stages where lower exposure is generally preferred, recognizing that interpretation should be cautious and guided by a clinician. For anyone, repeating the test after a meaningful change—like updating food-storage habits or completing a medical treatment cycle—helps confirm whether levels shift in the expected direction.

Superpower also tests for

See more diseases

Frequently Asked Questions About

What is a Mono-(2-ethyl-5-oxohexyl) Phthalate (MEOHP) test?

This test measures urinary mono-(2-ethyl-5-oxohexyl) phthalate (MEOHP), an oxidative metabolite and biomarker of exposure to the parent phthalate di(2-ethylhexyl) phthalate (DEHP). It reflects recent internal exposure to DEHP from sources such as PVC plastics, medical devices, food packaging, or dust, and is used to estimate body burden for exposure assessment and epidemiologic studies of phthalate-related health effects.

Should I test for Mono-(2-ethyl-5-oxohexyl) Phthalate (MEOHP)?

Testing for Mono-(2-ethyl-5-oxohexyl) phthalate (MEOHP) can be useful if you need an objective measure of recent exposure to DEHP, a common phthalate; MEOHP matters because phthalates are endocrine-active chemicals that can affect reproductive and developmental biology, hormone balance, and metabolic regulation—factors that may influence long‑term health and longevity. Sources include plastics (especially PVC and flexible plastics), food packaging and processing, some personal-care products, and medical devices; exposure is typically via diet, dust, or medical procedures. Health impacts linked to DEHP/MEOHP exposures include endocrine disruption (effects on fertility, testosterone and thyroid function), developmental concerns in children, and associations with metabolic outcomes; testing helps quantify exposure, identify likely sources, and track whether exposure‑reduction steps are effective.

People who benefit most from testing are those with high environmental or occupational exposure risk, pregnant people and children, individuals with unexplained reproductive or thyroid symptoms, patients undergoing frequent medical procedures involving plastics, and those focused on optimizing detox capacity or long‑term health—testing is practical for prioritizing and monitoring exposure‑reduction but is not a diagnostic or prescriptive medical intervention.

How often should I test for Mono-(2-ethyl-5-oxohexyl) Phthalate (MEOHP)?

Obtain a baseline MEOHP test once to assess current exposure, then consider periodic follow‑up testing if levels are elevated (for example every 3–12 months) or after significant lifestyle or environmental changes — for example “after changing household products” or “following detoxification efforts.”

What can affect Mono-(2-ethyl-5-oxohexyl) Phthalate (MEOHP) test results?

Several factors can affect Mono-(2-ethyl-5-oxohexyl) Phthalate (MEOHP) test results: timing of sample collection (levels change after exposure), recent exposures from food, air, water or consumer products, individual metabolism (age, genetics, liver function), hydration status (urine dilution), and the sample type and handling (urine vs blood, spot vs 24‑hour collection, storage and contamination); certain medications or dietary supplements may also influence measured MEOHP concentrations.

Are there any preparations needed before testing Mono-(2-ethyl-5-oxohexyl) Phthalate (MEOHP) levels?

No fasting is required before a Mono-(2-ethyl-5-oxohexyl) phthalate (MEOHP) test. A urine sample is normally used; some studies or labs prefer a first‑morning void for consistency, but a spot sample is generally acceptable — follow specific collection instructions from the testing lab or study if provided.

Because MEOHP reflects recent exposure (hours to days), it can help to avoid nonessential contact with likely phthalate sources for about 24–48 hours before sampling if feasible (e.g., minimize handling thermal receipts, foods packaged in plastic, use of vinyl/PVC items, and recent use of personal care products that may contain phthalates). Regardless, record and report any recent product use or environmental contact (plastics, personal care items, pesticides, medical procedures with plastic devices, changes in diet or packaging) and the timing of those exposures when you submit the sample.

How accurate is Mono-(2-ethyl-5-oxohexyl) Phthalate (MEOHP) testing?

Accuracy depends on sample timing (time since exposure and whether a first‑morning or spot urine was collected), the laboratory method (high-quality mass spectrometry methods such as LC‑MS/MS provide the best sensitivity and specificity), and consistent collection and handling (proper containers, avoidance of contamination, and dilution correction e.g., creatinine or specific gravity adjustment). Biological variability and the short half-life of phthalate metabolites mean repeat or appropriately timed sampling improves interpretation.

What happens if my Mono-(2-ethyl-5-oxohexyl) Phthalate (MEOHP) levels are outside the optimal or reference range?

If your MEOHP level is high, it most commonly means you have had recent or ongoing exposure to DEHP-containing products (for example certain plastics, food packaging, dust, or some personal-care items) or that your body is clearing the chemical more slowly than expected. Persistently elevated MEOHP can indicate a higher body burden of phthalates and has been associated in studies with effects on hormone function and reproductive or developmental outcomes, so it often prompts closer attention to exposure sources and medical follow-up.

If your MEOHP level is low or below the reference range, it generally suggests low recent exposure or efficient clearance and is usually not a concern on its own. Importantly, a single result should be interpreted in context — with other toxin measurements, your symptoms, lifestyle and occupational exposures, and health markers (like liver or kidney function) — because phthalate metabolites reflect recent exposure and can vary over time. Persistent abnormalities or worry about potential health effects should be discussed with a clinician who can interpret results alongside other tests and recommend monitoring or exposure-reduction steps if needed.

How do I interpret my Mono-(2-ethyl-5-oxohexyl) Phthalate (MEOHP) test results?

MEOHP is a urinary metabolite of the phthalate DEHP; higher-than-reference MEOHP levels generally indicate recent exposure to DEHP. Labs often report results as concentration (µg/L) and creatinine‑adjusted values (µg/g creatinine) or percentiles versus a reference population—use those references rather than a single cutoff. A single elevated result suggests exposure but not necessarily injury; interpret levels together with other phthalate metabolites (to confirm exposure pattern) and with clinical context (symptoms, timing of known exposures, occupation, product use).

Always review MEOHP alongside related toxin markers and body‑system indicators (for example, other phthalate metabolites, liver enzymes, kidney function/creatinine or eGFR, and oxidative‑stress/inflammation markers) and focus on trends over time rather than one isolated value. If levels are persistently elevated or rising, consider exposure reduction measures, repeat testing to confirm a trend, and discuss findings with your clinician to investigate sources and any needed medical evaluation or follow‑up.

How it works

1

Test your whole body

Get a comprehensive blood draw at one of our 3,000+ partner labs or from the comfort of your own home.

2

An Actionable Plan

Easy to understand results & a clear action plan with tailored recommendations on diet, lifestyle changes, supplements and pharmaceuticals.

3

A Connected Ecosystem

You can book additional diagnostics, buy curated supplements for 20% off & pharmaceuticals within your Superpower dashboard.

Superpower tests more than 
100+ biomarkers & common symptoms

Developed by world-class medical professionals

Supported by the world’s top longevity clinicians and MDs.

Dr Anant Vinjamoori

Superpower Chief Longevity Officer, Harvard MD & MBA

A smiling woman wearing a white coat and stethoscope poses for a portrait.

Dr Leigh Erin Connealy

Clinician & Founder of The Centre for New Medicine

Man in a black medical scrub top smiling at the camera.

Dr Abe Malkin

Founder & Medical Director of Concierge MD

Dr Robert Lufkin

UCLA Medical Professor, NYT Bestselling Author

membership

$17

/month
Billed annually at $199
A smartphone displays health app results, showing biomarker summary, superpower score, and biological age details.
A website displays a list of most ordered products including a ring, vitamin spray, and oil.
A smartphone displays health app results, showing biomarker summary, superpower score, and biological age details.A tablet screen shows a shopping website with three most ordered products: a ring, supplement, and skincare oil.
What could cost you $15,000 is $199

Superpower
Membership

Your membership includes one comprehensive blood draw each year, covering 100+ biomarkers in a single collection
One appointment, one draw for your annual panel.
100+ labs tested per year
A personalized plan that evolves with you
Get your biological age and track your health over a lifetime
$
17
/month
billed annually
Flexible payment options
Four credit card logos: HSA/FSA Eligible, American Express, Visa, and Mastercard.
Start your Women’s Health Check
Cancel anytime
HSA/FSA eligible
Results in a week
Pricing may vary for members in New York and New Jersey **

Finally, healthcare that looks at the whole you